SHARE
COPY LINK

COVID-19

European countries face slower vaccination as Johnson & Johnson delays rollout

Pharmaceutical company Johnson & Johnson is to delay the rollout of its Covid-19 vaccine in Europe due to concerns over rare potential side effects detected in the United States.

European countries face slower vaccination as Johnson & Johnson delays rollout
Photo: Kamil Krzaczynski/AFP/Ritzau Scanpix

The company confirmed the decision in a statement on Tuesday afternoon.

Rare cases of blood clots combined with low platelet numbers in persons who have received the vaccine are the background for the decision, the company said.

“We have made the decision to proactively delay the rollout of our vaccine in Europe,” Johnson & Johnson said in the statement.

“We have been working closely with medical experts and health authorities, and we strongly support the open communication of this information to healthcare professionals and the public,” it added.

According to the company, the United States Centers for Disease Control (CDC) and Food and Drug Administration (FDA) are reviewing data “involving six reported US cases out of more than 6.8 million doses administered”.

“Out of an abundance of caution, the CDC and FDA have recommended a pause in the use of our vaccine” in the United States, it said.

Vaccination programmes in several European countries could be impacted by the decision to delay rollout of the vaccine, which is also known as the Janssen vaccine after the Johnson & Johnson subsidiary which developed it.

France was scheduled to receive its first 200,000 doses of the Janssen vaccine this week. The vaccine has already been authorised for use on all age groups by French medical regulator Haute autorité de santé.

France’s rollout had been planned primarily through family doctors and pharmacies, while mass vaccination centres continue to rely more heavily on Pfizer and Moderna.

Nordic countries Sweden, Denmark and Norway were also due to receive their first doses of the Johnson & Johnson vaccine later this week, while the first delivery was received in Austria on Tuesday morning. 

READ ALSO: Danish government to propose ending Covid-19 travel restrictions for vaccinated persons

Sweden will decide how to use the vaccine within the coming days, the country’s health agency Folkhälsomyndigheten said earlier on Tuesday.

“We are looking at the issue and the data available from the European Medicines Agency and our American colleagues,” Sweden’s state epidemiologist Anders Tegnell said at a briefing, adding a decision would be announced “within one or a few days.”

Each of the Nordic countries has factored large-scale deliveries of the Johnson & Johnson vaccine into their vaccination calendars.

Sweden expected to receive 67,000 doses of the Janssen vaccine in April, a reduction on the 229,000 doses previously expected. Another 295,000 doses were set to arrive in May, and another 888,000 by the end of June.

Denmark has ordered more vaccine doses from Johnson & Johnson than from any other supplier, having earmarked 8.2 million doses. Those doses were scheduled to begin arriving from Wednesday.

“It is very important for us… before we initiate use in Denmark, to ascertain whether we, for example, need further documentation and scientific research, whether there should be certain provisions for use, whether it should be used (only) for certain target groups,” the director of the Danish Health Authority (Sundhedsstyrelsen) Søren Brostrøm told news wire Ritzau in a written comment.

Norway’s programme for vaccinating its population faces a setback of delays of up to 8-12 weeks if the country does not use the Janssen vaccine and also chooses not to reimplement the AstraZeneca vaccine, which remains suspended in the country, also due to concerns over side effects.

The estimate was given by department director Line Vold of the Norwegian Institute for Public Health (Folkehelseinstituttet) at a briefing on Tuesday afternoon.

“If both AstraZeneca and Johnson & Johnson are excluded, vaccination can be completed 8-12 weeks later provided other vaccines are delivered as promised,” Vold said.

Austria, which ordered 2.5 million doses of the vaccine for a population of 8.5 million, plans a heavy reliance on the Johnson & Johnson vaccine. 

On Tuesday morning, the first delivery of around 16,800 doses of the vaccine arrived in Austria. 

Austrian health authorities indicated that a plan to start administering the doses immediately would be temporarily suspended. 

“Until there is clarity about any side effects, these doses will not be delivered to the vaccination centres and will not be administered,” said a spokesperson for the Ministry of Health on Tuesday.

Member comments

  1. I haven’t heard anything bad about Sputnik V! LOL Why do they do difficult now? We still use astrazeneca after learning a few wil die but those people will save the lives of many others, so well worth. If it’s you? well….. so sorry, you’re a great person and will be remembered forever.
    When are international flights allowed? That’s the only question keeping me occupied.

    1. Very utilitarian thinking. You ask “if it’s you?” but I’m curious if you’ve asked “if it’s me?”? Would your response still be “So sorry, I’m a great person and will be remembered forever”?

      The people who die from side effects will not save others. The people who safely take vaccines will save others. In essence, people who die from vaccines are lives lost for no good reason, that could have been avoided. I’m not advocating rejecting astrazeneca/johnson but I also wouldn’t be so dismissive of the concerns of people regarding serious side effects either. We only have one life.

  2. David I agree with you, I personally think it is unacceptable that very young people die who would survive covid anyway. I find it very strange those people who died are barely noticed, while the first few dying from covid got covered in the news endlessly. Ofcourse if you see photo’s of the women and see their children or families hear what they did in life it becomes ‘personal’ and especially younger people will refuse the vaccins. If the news covers their stories, one a week, they have now nearly 2 years material!
    The goverments want us to believe it’s ‘nothing’, every medicine has side effects. Well that’s true and you choose those when you’re sick, here we are injecting healthy people, that’s the difference.
    Danark is testing aspitation (so you can see if you’ve hit a vein) before injecting, let hope this will be the answer. To be clear I only wrote what was told, I personally do not want anyone to die from a vaccine,

Log in here to leave a comment.
Become a Member to leave a comment.

TRAVEL NEWS

Covid face mask rule on flights in Europe set to be eased

The mandatory EU-wide mask requirement for air travel is set to be dropped from Monday, May 16th, but airlines may still require passengers to wear masks on some or all flights

Covid face mask rule on flights in Europe set to be eased

Europe-wide facemask rules on flights are set to be ditched as early as next week in light of new recommendations from health and air safety experts.

The European Union Aviation Safety Agency (EASA) and European Centre for Disease Prevention and Control (ECDC) dropped recommendations for mandatory mask-wearing in airports and during flights in updated Covid-19 safety measures for travel issued on Wednesday, May 11th.

The new rules are expected to be rolled out from Monday, May 16th, but airlines may still continue to require the wearing of masks on some or all of flights. And the updated health safety measures still say that wearing a face mask remains one of the best ways to protect against the transmission of the virus.

The joint EASA/ECDC statement reminded travellers that masks may still be required on flights to destinations in certain countries that still require the wearing of masks on public transport and in transport hubs.

It also recommends that vulnerable passengers should continue to wear a face mask regardless of the rules, ideally an FFP2/N95/KN95 type mask which offers a higher level of protection than a standard surgical mask.

“From next week, face masks will no longer need to be mandatory in air travel in all cases, broadly aligning with the changing requirements of national authorities across Europe for public transport,” EASA executive director Patrick Ky said in the statement. 

“For passengers and air crews, this is a big step forward in the normalisation of air travel. Passengers should however behave responsibly and respect the choices of others around them. And a passenger who is coughing and sneezing should strongly consider wearing a face mask, for the reassurance of those seated nearby.”  

ECDC director Andrea Ammon added: “The development and continuous updates to the Aviation Health Safety Protocol in light of the ongoing Covid-19 pandemic have given travellers and aviation personnel better knowledge of the risks of transmission of SARS-CoV-2 and its variants. 

“While risks do remain, we have seen that non-pharmaceutical interventions and vaccines have allowed our lives to begin to return to normal. 

“While mandatory mask-wearing in all situations is no longer recommended, it is important to be mindful that together with physical distancing and good hand hygiene it is one of the best methods of reducing transmission. 

“The rules and requirements of departure and destination states should be respected and applied consistently, and travel operators should take care to inform passengers of any required measures in a timely manner.”

SHOW COMMENTS